In support of this, reduced circulating levels of leptin is a common feature in AD patients (Power et al., 2001) and in rodent models of AD (Farr et al., 2006), which has fueled the possibility that the leptin system may be therapeutically useful in age-related disorders such as AD. The gene discussed is LEP; the disease is Alzheimer disease.